Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

Presentation TCT Abstracts Posters 2018

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Presenter: Woo-Young Chung

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Presenter: Krzysztof Milewski

September 25, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2018

TCT-197: Early Vascular Healing After Implantation of a Biolimus-Coated BioFreedom Stent or a Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction

Presenter: Alexandre Abizaid, Didier Carrié, Kirstine Hansen

September 21, 2018

Presentation TCT 2018

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Ricardo A. Costa

September 21, 2018

Presentation TCT 2018

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Presenter: George L Adams, Tony Das, Gireesh Warwadekar

September 21, 2018

Presentation TCT 2018

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Presenter: Bernardo Cortese

September 21, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

Presentation TCT 2018

Novasight HybridTM A Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomography Imaging System (Conavi Medical Inc.)

Presenter: Brian K Courtney

September 21, 2018

Presentation TCT 2018

Cellular-Resolution Intravascular Optical Coherence Tomography for Human Coronary Artery Imaging

Presenter: Biwei Yin

September 21, 2018

Presentation TCT 2018

A New Device to Markedly Reduce Cardiac Cath Lab Radiation Levels (Egg Medical)

Presenter: Robert Wilson

September 21, 2018

Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 23, 2018

Presentation JIM 2018

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Presenter: Luca Testa

February 22, 2018

Advertisement

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

TCT-197: Early Vascular Healing After Implantation of a Biolimus-Coated BioFreedom Stent or a Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Novasight HybridTM A Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomography Imaging System (Conavi Medical Inc.)

Cellular-Resolution Intravascular Optical Coherence Tomography for Human Coronary Artery Imaging

A New Device to Markedly Reduce Cardiac Cath Lab Radiation Levels (Egg Medical)

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content